Skip to content

Clinical trials

Disease Progression trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Country / region: China Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20101
20112
20132
20152
20161
20172
20183
20191
20203
20212
20225
20234
20245
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting20
Completed10
Unknown status10
Not yet recruiting4
Active, not recruiting3
Terminated1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital4
Peking University People's Hospital4
Fudan University3
Shanghai Zhongshan Hospital3
Huazhong University of Science and Technology2
Second Xiangya Hospital of Central South University2
AstraZeneca1
Bayer1
Beijing Friendship Hospital1
Beijing Municipal Administration of Hospitals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression50
Coronary Artery Disease3
Coronary Restenosis3
Coronary Stenosis3
Inflammation3
Neoplasms3
Parkinson Disease3
Alzheimer Disease2
Breast Neoplasms2
Carcinoma, Hepatocellular2

Trials

Showing 51 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.